Redcare Pharmacy NV (BIT:1RDC)

Redcare Pharmacy NV Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	104.02	96.89	84.16	66.78	247.41	90.49
Short-Term Investments	80.8	80.66	120	113.32	36.42	37.77
Cash & Short-Term Investments	184.82	177.56	204.16	180.1	283.83	128.26
Cash Growth	-15.55%	-13.03%	13.36%	-36.55%	121.30%	13.27%
Accounts Receivable	116.21	109.87	103.13	30	27.92	29.98
Other Receivables	-	14.99	16.17	10.94	8.25	-
Receivables	116.21	124.86	119.31	40.95	36.16	29.98
Inventory	161.53	153.82	135.79	99.71	96.62	81.24
Prepaid Expenses	52	17.99	10.89	6.57	3.7	4.71
Other Current Assets	-	25.79	29.38	16.59	12.45	9.91
Total Current Assets	514.56	500.02	499.52	343.92	432.76	254.09
Property, Plant & Equipment	90.23	82.57	86.91	85.44	78.26	74.55
Long-Term Investments	1.42	1.42	1.31	1.27	1.47	1.77
Goodwill	-	277.5	277.5	169.57	153.13	129.12
Other Intangible Assets	407.17	133.82	150.61	119.43	104.35	75.54
Long-Term Deferred Tax Assets	1.41	1.41	2.3	0.46	-	0.12
Other Long-Term Assets	6.91	6.55	3.46	9.39	13.11	1.73
Total Assets	1,022	1,003	1,022	729.47	783.08	536.91
Accounts Payable	212.72	175.29	152	68.94	78.12	51.32
Accrued Expenses	-	55.56	56.79	38.64	36.38	15.65
Short-Term Debt	-	-	-	-	0.04	0.04
Current Portion of Long-Term Debt	9.84	1.63	1.63	1.67	1.63	-
Current Portion of Leases	-	8.1	7.15	5.88	4.74	5.38
Current Income Taxes Payable	-	0.46	0.57	0.24	0.78	0.39
Other Current Liabilities	63.52	8.7	5.6	3.94	2.41	1.82
Total Current Liabilities	286.09	249.73	223.72	119.31	124.09	74.61
Long-Term Debt	236.98	209.14	204.35	199.75	195.38	4.08
Long-Term Leases	-	27.68	30.68	27.59	26.06	28.73
Long-Term Deferred Tax Liabilities	2.63	3.57	6.32	7.89	13.55	4.35
Other Long-Term Liabilities	-	-	-	14.62	2.65	-
Total Liabilities	528.03	493.32	469.56	374.84	367.66	111.77
Common Stock	755.62	0.4	0.4	0.36	0.36	0.35
Additional Paid-In Capital	-	754.9	733.03	570.7	566.54	551.67
Retained Earnings	-	-324.29	-279.26	-285.43	-207.78	-133.72
Comprehensive Income & Other	-281.75	52.97	68.03	69	56.3	6.84
Total Common Equity	473.87	483.98	522.19	354.63	415.41	425.14
Minority Interest	19.8	25.99	29.84	-	-	-
Shareholders' Equity	493.67	509.97	552.03	354.63	415.41	425.14
Total Liabilities & Equity	1,022	1,003	1,022	729.47	783.08	536.91
Total Debt	246.82	246.54	243.79	234.89	227.84	38.23
Net Cash (Debt)	-62	-68.99	-39.63	-54.79	55.99	90.02
Net Cash Growth	-	-	-	-	-37.80%	-
Net Cash Per Share	-	-3.44	-2.06	-3.05	3.13	6.26
Filing Date Shares Outstanding	-	20.34	20.2	18.2	18.1	17.94
Total Common Shares Outstanding	-	20.34	20.2	18.2	18.1	17.94
Working Capital	228.48	250.29	275.79	224.61	308.68	179.47
Book Value Per Share	-	23.79	25.85	19.49	22.96	23.70
Tangible Book Value	66.7	72.67	94.09	65.63	157.94	220.48
Tangible Book Value Per Share	-	3.57	4.66	3.61	8.73	12.29
Land	-	6.61	5.3	6.43	37.88	40.95
Machinery	-	53.45	49.74	43.53	35.25	12.29
Construction In Progress	-	1.06	0.73	3.82	5.92	22.29

Source: S&P Global Market Intelligence. Standard template. Financial Sources.